Auranofin repurposing for lung and pancreatic cancer : low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition
Bron
Journal of Experimental and Clinical Cancer Research - ISSN 1756-9966-43:1 (2024) p. 1-15
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles
Bron
Journal of translational medicine - ISSN 1479-5876-22:1 (2024) p. 1-16
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer
Bron
npj Precision Oncology - ISSN 2397-768X-7:1 (2023) p. 1-14